Mereo BioPharma Group PLC (MREO)
3.68
+0.10
(+2.79%)
USD |
NASDAQ |
Nov 21, 16:00
3.675
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Market Cap: 570.94M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 570.94M |
| November 20, 2024 | 555.42M |
| November 19, 2024 | 541.46M |
| November 18, 2024 | 516.63M |
| November 15, 2024 | 547.66M |
| November 14, 2024 | 592.66M |
| November 13, 2024 | 628.34M |
| November 12, 2024 | 636.10M |
| November 11, 2024 | 664.02M |
| November 08, 2024 | 659.17M |
| November 07, 2024 | 632.86M |
| November 06, 2024 | 634.41M |
| November 05, 2024 | 634.41M |
| November 04, 2024 | 620.49M |
| November 01, 2024 | 662.26M |
| October 31, 2024 | 651.43M |
| October 30, 2024 | 657.62M |
| October 29, 2024 | 651.43M |
| October 28, 2024 | 649.88M |
| October 25, 2024 | 659.17M |
| October 24, 2024 | 673.10M |
| October 23, 2024 | 657.62M |
| October 22, 2024 | 676.19M |
| October 21, 2024 | 700.95M |
| October 18, 2024 | 714.87M |
| Date | Value |
|---|---|
| October 17, 2024 | 705.59M |
| October 16, 2024 | 697.85M |
| October 15, 2024 | 702.49M |
| October 14, 2024 | 691.66M |
| October 11, 2024 | 671.55M |
| October 10, 2024 | 637.51M |
| October 09, 2024 | 640.60M |
| October 08, 2024 | 643.70M |
| October 07, 2024 | 657.62M |
| October 04, 2024 | 680.83M |
| October 03, 2024 | 680.83M |
| October 02, 2024 | 663.81M |
| October 01, 2024 | 645.24M |
| September 30, 2024 | 635.96M |
| September 27, 2024 | 636.95M |
| September 26, 2024 | 630.80M |
| September 25, 2024 | 615.41M |
| September 24, 2024 | 623.10M |
| September 23, 2024 | 629.26M |
| September 20, 2024 | 653.87M |
| September 19, 2024 | 658.49M |
| September 18, 2024 | 649.26M |
| September 17, 2024 | 607.72M |
| September 16, 2024 | 692.34M |
| September 13, 2024 | 658.49M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
19.92M
Minimum
Mar 18 2020
749.26M
Maximum
Aug 26 2024
240.93M
Average
179.55M
Median
Market Cap Benchmarks
| NuCana PLC | 2.853M |
| TC BioPharm (Holdings) PLC | 0.3114M |
| Biodexa Pharmaceuticals PLC | 2.556M |
| Adaptimmune Therapeutics PLC | 162.90M |
| Bicycle Therapeutics PLC | 1.399B |
Market Cap Related Metrics
| Price to Book Value | 7.871 |
| Price | 3.68 |
| Earnings Yield | -8.15% |